Universitaetsklinikum Tuebingen AöR

Hematology and Cell Therapy

Clinical research includes acute myeloid leukemia, myelodysplastic neoplasms, chronic lymphocytic leukemia, lymphoma, and acute lymphoblastic leukemia, with activity across relapsed, refractory, and post-transplant settings.

  • Allogeneic stem cell transplantation
  • B-cell malignancies
  • Minimal residual disease
  • Leukemia vaccination

Research also covers fusion-driven sarcomas, fibrolamellar hepatocellular carcinoma, and immunotherapy-based approaches in advanced blood cancers and solid tumors.

Neuro-oncology and Neurology

Trials address glioblastoma, leptomeningeal disease, Parkinson disease, and disorders of brain injury and impaired vigilance, including hypoxic-ischemic encephalopathy and unresponsive wakefulness syndrome.

  • Intrathecal immunotherapy
  • Dopaminergic symptom control
  • Neurorecovery
  • Consciousness impairment

Additional work includes treatment strategies for chronic depression and neurological complications associated with severe illness.

Ophthalmology and Inherited Retinal Disease

Research activity includes acute central retinal artery occlusion, retinopathy of prematurity, achromatopsia, and retinitis pigmentosa, spanning both acquired and genetic causes of vision loss.

  • Retinal ischemia
  • Gene therapy
  • Prematurity-related eye disease
  • Visual function recovery

The portfolio reflects interest in restoring or preserving retinal function in paediatric and adult populations.

Pediatric, Neonatal, and Respiratory Care

Trials focus on extremely preterm infants, prematurity complications, and neonatal outcomes after asphyxia, with attention to respiratory support and neurodevelopment.

  • Mechanical ventilation
  • Therapeutic hypothermia
  • Neurodevelopmental impairment
  • Retinopathy of prematurity

Research also includes prevention and management of neonatal complications in intensive care settings.

Oncology, Metabolic Disease, and Infectious Disease

Studies extend to prostate cancer, rectal cancer, melanoma, and prediabetes, alongside work in malaria, COVID-19, and Staphylococcus aureus colonization.

  • PSMA-targeted therapy
  • Radiochemotherapy
  • Glucose metabolism
  • Vaccine immunogenicity

These trials encompass both cancer-directed treatment and prevention-oriented research in infectious and metabolic conditions.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Early Detection of Side Effects in Metastatic Melanoma Patients Using Zirconium (89Zr) Crefmirlimab Berdoxam Imaging

    Recruiting

    2 1 1
    Investigated Diseases:
    Germany
  • Study on Ketamine and CBASP for Treating Chronic Depression in Adults

    Recruiting

    2 1 1
    Investigated Diseases:
    Germany
  • Study of Nivolumab for Patients with Metastatic Solid Tumors and Leptomeningeal Disease

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on Bevacizumab for Patients with Newly Diagnosed IDH Wild-Type, MGMT Unmethylated Glioblastoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study of Venetoclax and Decitabine for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on Dapagliflozin and Lifestyle Changes for Patients with Early Chronic Kidney Disease and Prediabetes

    Recruiting

    3 1 1
    Investigated Drugs:
    Germany